- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means

S. 864
U.S. Senate•In Senate Committee
Summary
S. 864, the HELP Copays Act, was introduced in the Senate on Mar 5, 2025 by Sen. Roger Marshall (R) with 27 co-sponsors. It was referred to Health, Education, Labor, And Pensions, and last saw action on Mar 19, 2026: Committee on Health, Education, Labor, and Pensions. Hearings held.
Record
Text
S. 864 has 27 co-sponsors.
sb864/introduced-in-senate.txt119 S864 IS: Help Ensure Lower Patient Copays ActU.S. Senate2025-03-05text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.II 119th CONGRESS 1st Session S. 864 IN THE SENATE OF THE UNITED STATES March 5, 2025 Mr. Marshall (for himself, Mr. Kaine , Mr. Tillis , Mr. Markey , Ms. Murkowski , and Mr. Merkley ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILLTo amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes.1.Short titleThis Act may be cited as the Help Ensure Lower Patient Copays Act or the HELP Copays Act .2.Application of financial assistance toward cost-sharing requirements(a)Application toward cost-Sharing requirementsSection 2715(g)(1) of the Public Health Service Act ( 42 U.S.C. 300gg–15(g)(1) ) is amended by adding at the end the following: In developing the standards for defining the terms deductible , coinsurance , copayment , and out-of-pocket limit (as described in paragraph (2)), such standards shall provide that such terms include amounts paid by, or on behalf of, an individual enrolled in a group health plan or group or individual health insurance coverage, including financial assistance offered by non-profit organizations and prescription drug manufacturers, and that such amounts shall be counted toward such deductible, coinsurance, copayment, or limit, respectively. .(b)Conforming amendments(1)PPACASection 1302(c)(3) of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18022(c)(3) ) is amended by adding at the end the following new subparagraph:(C)Application of termsFor purposes of subparagraph (A), the terms deductible , coinsurance , copayment , or similar charge and any other expenditure described in clause (ii) of such subparagraph shall include amounts paid by, or on behalf of, an individual enrolled in a group health plan or group or individual health insurance coverage, including financial assistance offered by non-profit organizations and prescription drug manufacturers, and such amounts shall be counted toward such deductible, co-insurance, co-payment, charge, or other expenditure, respectively..(2)PHSASection 2707(b) of the Public Health Service Act ( 42 U.S.C. 300gg–6(b) ) is amended by adding at the end the following new sentence: For purposes of the previous sentence, such limitation shall be applied to prescription drugs as if the reference to essential health benefits in section 1302(c)(3) of the Patient Protection and Affordable Care Act were a reference to any item or service covered under the plan included within the prescription drug category of essential health benefits as described in (b)(1)(F) of such section . .(3)Internal Revenue Code of 1986 safe harbor for certain amounts applied to deductiblesSection 223(c)(2) of the Internal Revenue Code of 1986 is amended by adding at the end the following new subparagraph:(H)Safe harbor for certain amounts applied to deductiblesIn the case of plan years beginning after December 31, 2025, a plan shall not fail to be treated as a high deductible health plan by reason of counting amounts paid by, or on behalf of, an individual, including financial assistance offered by non-profit organizations and prescription drug manufacturers for outpatient prescription drugs, when determining whether the minimum deductible under subparagraph (A) has been satisfied..(c)Rule of constructionThe amendments made by this section shall —(1)apply to standards relating to deductibles, coinsurance, copayments, or limits with respect to prescription drugs that are specialty drugs;(2)apply to standards relating to deductibles, coinsurance, copayments, or limits with respect to drugs that are subject to utilization management; and(3)not impact the use of utilization management tools, including prior authorization and step therapy.(d)Effective dateThis section, and the amendments made by this section, shall apply to group health plans and health insurance issuers for plan years beginning on or after January 1, 2026.
Tracker
The tracker indicates the progress of this legislation as it moves through the legislative process.
- Introduced2025-03-05
- Passed Senate
- Passed House
- Conference
- To President
- Became Law
A bill to amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes.
Sponsors
Sen. Roger Marshall (R) sponsors S. 864, and 27 members have co-sponsored it, 5 of them from the day it was introduced.

Sen. · R–KS · Sponsor
Introduced Mar 5, 2025

Sen. · D–VA · Co-sponsor
Joined Mar 5, 2025 · Original

Sen. · D–MA · Co-sponsor
Joined Mar 5, 2025 · Original

Sen. · D–OR · Co-sponsor
Joined Mar 5, 2025 · Original

Sen. · R–AK · Co-sponsor
Joined Mar 5, 2025 · Original

Sen. · R–NC · Co-sponsor
Joined Mar 5, 2025 · Original

Sen. · R–NC · Co-sponsor
Joined Mar 13, 2025

Sen. · R–WV · Co-sponsor
Joined Mar 13, 2025

Sen. · D–DE · Co-sponsor
Joined Mar 13, 2025

Sen. · D–WA · Co-sponsor
Joined Mar 13, 2025
Committees
S. 864 went before 1 committee: Health, Education, Labor, and Pensions.

Actions
S. 864 has taken 3 actions since Mar 5, 2025, the latest on Mar 19, 2026.
| Chamber | Action | |||
|---|---|---|---|---|
Mar 19, 2026 | Senate | Committee on Health, Education, Labor, and Pensions. Hearings held.Health, Education, Labor, and Pensions Committee | ||
Mar 5, 2025 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Health, Education, Labor, and Pensions Committee | ||
Mar 5, 2025 | — | Introduced in Senate |
Votes
S. 864 has not gone to a roll call.
Related bills
1 bill is related to S. 864, as Identical bill.
Titles
S. 864 goes by 4 titles, 2 of them short titles.
- HELP Copays Act — Display Title
- HELP Copays Act — Short Title(s) as Introduced
- Help Ensure Lower Patient Copays Act — Short Title(s) as Introduced
- A bill to amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. — Official Title as Introduced
Lobbying
42 clients hired 36 firms and 241 registered lobbyists who named S. 864 in 212 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.
Filed under Health Issues, Medicare/Medicaid, Pharmacy, Budget/Appropriations, Taxation/Internal Revenue Code, Trade (domestic/foreign), Copyright/Patent/Trademark, Veterans.
Clients
Who paid to be heard, by how many filings named the bill. The 20 that filed most often, of 42.
| Client | Business | State | Firms | Filings | Reported |
|---|---|---|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | Trade association representing biopharmaceutical research companies. | District of Columbia | 2 | 10 | $400K |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | no change | District of Columbia | 2 | 9 | $360K |
| NOVARTIS | — | District of Columbia | 1 | 8 | — |
| UCB, INC. | Biopharmaceutical company | Georgia | 2 | 7 | $380K |
| GSK (FKA GLAXOSMITHKLINE INC.) | — | District of Columbia | 1 | 7 | — |
| THE ALS ASSOCIATION | — | Virginia | 1 | 7 | — |
| VERTEX PHARMACEUTICALS INCORPORATED | — | Massachusetts | 1 | 7 | — |
| JOHNSON & JOHNSON SERVICES, INC. | Pharmaceutical and medical technologies corporation. | New Jersey | 1 | 6 | $440K |
| EMD SERONO INC. | Biopharmaceutical business. | District of Columbia | 1 | 6 | $300K |
| BRISTOL-MYERS SQUIBB COMPANY | — | District of Columbia | 2 | 6 | $290K |
| MERCK & CO., INC. | Pharmaceutical Company. | District of Columbia | 1 | 6 | $280K |
| PATIENT ACCESS NETWORK FOUNDATION | Non-profit, charitable patient assistance program | District of Columbia | 1 | 6 | $240K |
| AMERICAN BANKERS ASSOCIATION | trade association for the U.S. banking industry | District of Columbia | 1 | 6 | $120K |
| ABBVIE INC. | — | District of Columbia | 1 | 6 | — |
| AMERICAN ACADEMY OF OPHTHALMOLOGY | — | District of Columbia | 1 | 6 | — |
| AMERICAN COLLEGE OF RHEUMATOLOGY | — | Georgia | 1 | 6 | — |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | — | District of Columbia | 1 | 6 | — |
| ARTHRITIS FOUNDATION | — | District of Columbia | 1 | 6 | — |
| ASSOCIATION FOR CLINICAL ONCOLOGY | — | Virginia | 1 | 6 | — |
| CYSTIC FIBROSIS FOUNDATION | — | Maryland | 1 | 6 | — |
Firms
Registrants who filed on the bill, by filings.
Lobbyists
Named on the filings that cite the bill. The 20 named most often, of 241.
| Lobbyist | Firms | Clients | Filings |
|---|---|---|---|
| DANIEL TODD | 1 | 6 | 30 |
| ERIC BERGREN | 1 | 6 | 30 |
| PAUL EDATTEL | 1 | 6 | 30 |
| KATHERINE COTTON | 1 | 5 | 24 |
| TED LEHMAN | 1 | 6 | 18 |
| JEFF LUCAS | 1 | 5 | 15 |
| NICHOLAS UEHLECKE | 1 | 2 | 12 |
| JEANNE HAGGERTY | 1 | 3 | 11 |
| SUSAN HIRSCHMANN | 1 | 3 | 11 |
| CHRISTOPHER HATCHER | 1 | 3 | 8 |
| COURTNEY LEE-ASHLEY | 1 | 1 | 8 |
| COURTNEY PIRON | 1 | 1 | 8 |
| JOSEPH MCGOWAN | 1 | 1 | 8 |
| SARAH DURR | 1 | 1 | 8 |
| TAYLOR BOOTH | 1 | 1 | 8 |
| THOMAS SUTER | 1 | 1 | 8 |
| DANIEL CRAMER | 1 | 1 | 7 |
| DENISE DEMICHELE-BAILIN | 1 | 1 | 7 |
| EMILY MICHAEL | 2 | 2 | 7 |
| HANNAH CORNWELL | 1 | 1 | 7 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.
| Client | Registrant | Period | Reported | Document |
|---|---|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2026 first_quarter | $12.2M | 1st Quarter - Report |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2025 third_quarter | $9M | 3rd Quarter - Report |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2025 fourth_quarter | $8.4M | 4th Quarter - Report |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2026 second_quarter | $7.4M | 2nd Quarter - Report |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | 2026 first_quarter | $5.3M | 1st Quarter - Report |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | 2025 first_quarter | $4.8M | 1st Quarter - Report |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL-MYERS SQUIBB COMPANY | 2025 second_quarter | $4.8M | 2nd Quarter - Report |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | 2025 third_quarter | $4.2M | 3rd Quarter - Report |
| NOVARTIS | NOVARTIS | 2025 first_quarter | $4.2M | 1st Quarter - Report |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | 2025 fourth_quarter | $4.1M | 4th Quarter - Report |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 2025 first_quarter | $4.1M | 1st Quarter - Report |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | 2025 second_quarter | $4.1M | 2nd Quarter - Report |
| NOVARTIS | NOVARTIS | 2026 first_quarter | $3.9M | 1st Quarter - Report |
| JOHNSON & JOHNSON SERVICES INC | JOHNSON & JOHNSON SERVICES, INC. | 2026 first_quarter | $3.5M | 1st Quarter - Report |
| CVS HEALTH (AND SUBSIDIARIES) | CVS HEALTH (AND SUBSIDIARIES) | 2025 first_quarter | $3.5M | 1st Quarter - Report |
| THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) | 2025 first_quarter | $3.5M | 1st Quarter - Report |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 2025 second_quarter | $3.4M | 2nd Quarter - Report |
| JOHNSON & JOHNSON SERVICES INC | JOHNSON & JOHNSON SERVICES, INC. | 2025 first_quarter | $3.3M | 1st Quarter - Report |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL-MYERS SQUIBB COMPANY | 2025 third_quarter | $3.2M | 3rd Quarter - Report |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | 2026 second_quarter | $3M | 2nd Quarter - Report |
Classification
The Congressional Research Service files S. 864 under Health, one of its 31 policy areas, and gives it 1 legislative subject.
CRS Subjects
CRS assigns every bill one policy area from its 31; S. 864’s is Health.
s864/policy-areas.txtLegislative Subjects
S. 864 carries 1 of CRS’s legislative subject: Health care costs and insurance.
s864/subjects.txtSource: congress.gov · legiscan.com
